UF Pharmacy breaks poster record at 33rd Annual Research Showcase

The UF College of Pharmacy’s 2020 Annual Research Showcase featured a record number of poster presentations, as the popularity of the event builds year after year. The 105 poster and nine oral presentations explored diverse topics, including how not to grow marijuana and the relationship between asthma medications and type 2 diabetes. Headlining the event was keynote speaker Stephen Hecht, Ph.D., from the University of Minnesota School of Medicine.

Graduate student presents poster at research showcase
Kelton Schleyer, a graduate student in the department of medicinal chemistry, presents his poster at the 2020 Annual Research Showcase.

Pharm.D. students, graduate students, postdoctoral fellows and undergraduates had the opportunity to share research findings and compete for awards in either oral or poster competitions. The showcase gave faculty and students the opportunity to come together, identify common ideas and explore research collaborations.

Keynote speaker Hecht, a professor of cancer prevention, gave an address titled, “Interdisciplinary collaborative research on tobacco carcinogens, their biomarkers, and cancer prevention.” Hecht’s presentation covered how he identifies individuals most susceptible to cancer-causing effects of tobacco to target them for prevention. His laboratory develops and applies tobacco carcinogen and toxicant biomarkers to help identify these susceptible individuals.


Oral presentation winners

Molly McDougle presents at the annual research showcaseJunior Division

Molly McDougle, Pharmacodynamics: Fats and sugars recruit distinct peripheral neural circuits to the brain


Mohammed Gbasamosi presents at the annual research showcaseSenior: Basic Sciences Division

Mohammed Gbadamosi, Pharmacotherapy and Translational Research: Novel CD33 antibodies reveal therapeutic implications of CD33 splicing variant


Cheng Chen presents at the annual research showcaseSenior: Clinical Sciences Division

Cheng (Alice) Chen, Pharmaceutical Outcomes and Policy: Use of prescription gabapentinoids and the risk of opioid-related adverse events

Poster presentation winners

Graduate Student Research: Cancer

  • Lais da Silva, Pharmaceutics: Novel STAT3 inhibitor reduces cellular plasticity in mouse pancreatic organoids

Graduate Student Research: Infectious Diseases

  • Lobna Elsadek, Medicinal Chemistry: Genomic and targeted approaches unveil targets of an antifungal natural product

Graduate Student Research: Pain/Addiction/CNS Disorders

  • Wanhui Sheng, Pharmacodynamics: Mechanisms governing dendritic release of oxytocin in the CNS

Graduate Student Research: Drug Interactions and Outcomes

  • Karthik Lingineni, Pharmaceutics: Quantitative benefit-risk assessment of P-gp mediated DDI of Dabigatran

Graduate Student Research: Chronic Disease

  • Lakshmi Manasa Chekka, Pharmacotherapy and Translational Research: Harnessing the potential of race in precision medicine: Thiazide outcomes study

Postdoctoral Trainee Research: Basic Science

  • Sajid Khan, Pharmacodynamics: DT2216, a BCL-XL PROTAC, is a safer and more potent antitumor agent than ABT263

Postdoctoral Trainee Research: Clinical Science

  • Roya Rafiee, Pharmacotherapy and Translational Research: GeCKO etoposide resistance screening predicts clinical outcome in AML-02 cohort

Undergraduate Research

  • Alyssa Gosling, Pharmaceutics: Human organoids to study racial disparity in pancreatic acinar ductal metaplasia

Pharm.D. Research

  • Akhila DadwaiSingle nucleotide polymorphism in gens of prognostic significance in AML
  • Yael MarksInvestigation of pharmacist recommendations in a pharmacogenetics consult clinic